Vimta Labs Ltd Share Price
As on 13 June 2026 at 03:48 IST
Vimta Labs Q1 FY26 Results:
Net profit for the period rose 53.7% to ₹18.9 crores in Q1 FY26, up from ₹12.3 crores in Q1 FY25. Total income for the quarter increased 31.4% year-on-year to ₹99.3 crores from ₹75.6 crores.
About Vimta Labs Ltd
Vimta Labs Limited is a well-known contract research and testing organisation based in India. Founded in 1984, it has been in business for decades and has a lot of experience in the field. The company provides a variety of services, including analytical testing, clinical research, preclinical studies, safety testing, method development, process validation, and environmental assessments. Its promoters have played a key role in building Vimta Labs into a trusted provider of research and testing services. Some of the main services offered include clinical research and analytical testing of some products. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
6.32%
Over 6 Months
-12.15%
Over 1 Year
6.96%
Over 3 Years
148.39%
Vimta Labs Ltd Summary
Close ₹521.25
Open ₹517
High ₹533.50
Low ₹513.60
Volume 1,83,719
Net Turnover (in Cr) ₹9.6
52Wk High ₹902.65
52Wk Low ₹376.05
52Wk High / Low
376.05
902.65
Vimta Labs Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹2,328.39
EPS (TTM) 17.65
Book Value (BV) 102.28
Div. Yield 0.38 %
P/E (TTM) 30.03
Price/Book Value 5.09
Delivery % 26.88 %
Face Value 2
Key Ratios
PE Ratio 21.95
PB Ratio 3.72
EV to Sales 4.02
PEG Ratio -0.51
ROA 15.55
ROE 18.55
Debt-Equity 0.01
Net Profit Margin 19.03
Operating Profit Margin 36.56
Vimta Labs Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 322.27 | 321.63 | 279.73 | 211.51 | 183.73 |
| Total Expenses | 267.79 | 256.64 | 222.82 | 182.97 | 175.46 |
| Profit Before Tax | 54.48 | 65 | 55.69 | 28.54 | 8.27 |
| Profit After Tax | 41.01 | 48.17 | 41.33 | 21.41 | 6.84 |
| Operating Profit After Depreciation | 56.60 | 67.64 | 58.41 | 30.71 | 12.04 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 171.11 | 174.80 | 168.72 | 134.75 | 137.97 |
| Total Non Current Assets | 242.45 | 198.67 | 182.84 | 163.82 | 149.91 |
| Total Current Assets | 157.60 | 163.66 | 124.36 | 110.54 | 95.86 |
| Total Assets | 400.05 | 362.32 | 307.20 | 274.36 | 245.77 |
| Total Shareholder's Fund | 319.70 | 281.79 | 233.98 | 194.38 | 172.88 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 60.89 | 87.94 | 59.07 | 37.18 | 24.35 |
| Net Cash Used In Investing Activities | -76.05 | -57.26 | -37.85 | -31.92 | -20.84 |
| Net Cash Used In Financing Activities | -1.90 | -10.98 | -16.61 | -4.57 | -0.67 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Revenue | 416.28 | 348.22 | 292.31 | 318.58 | 277.43 |
| Total Expenses | 310.71 | 259.22 | 229.80 | 254.75 | 220.86 |
| Profit Before Tax | 103.95 | 89 | 62.50 | 63.83 | 55.35 |
| Profit After Tax | 77.51 | 66.75 | 48.81 | 47.30 | 41.06 |
| Operating Profit After Depreciation | 106.74 | 90.90 | 64.61 | 66.47 | 58.07 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Fixed Assets | 305.13 | 229.99 | 165.53 | 167.86 | 161.64 |
| Total Non Current Assets | 337.36 | 278.72 | 236.87 | 197.69 | 181.63 |
| Total Current Assets | 224.87 | 187.82 | 157.60 | 162.78 | 124.60 |
| Total Assets | 562.23 | 466.53 | 394.47 | 360.47 | 306.23 |
| Total Shareholder's Fund | 456.87 | 378.85 | 314.12 | 280.58 | 233.65 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 147.14 | 94.05 | 60.89 | 86.51 | 58.67 |
| Net Cash Used In Investing Activities | -129.66 | -75.54 | -76.05 | -56.93 | -37.88 |
| Net Cash Used In Financing Activities | -10.35 | -16.12 | -1.90 | -10.66 | -16.14 |
| Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
|---|---|---|---|---|---|
| Total Revenue | 89.92 | 84.74 | 74.88 | 79.69 | 74.58 |
| Total Expenses | 56.84 | 56.61 | 50.57 | 55.27 | 52.80 |
| Profit Before Tax | 27.90 | 20.11 | 16.55 | 16.29 | 13.52 |
| Profit After Tax | 21.50 | 15.25 | 12.28 | 12.35 | 10.13 |
| Operating Profit after Depreciation | 38.29 | 28.81 | 25 | 24.91 | 22.48 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 109.25 | 98.63 | 101.85 | 97.56 | 94.44 |
| Total Expenses | 69.88 | 64.40 | 67.62 | 63.88 | 61.41 |
| Profit Before Tax | 29.05 | 23.36 | 26.28 | 25.25 | 25.02 |
| Profit After Tax | 21.11 | 17.59 | 19.92 | 18.89 | 18.32 |
| Operating Profit after Depreciation | 42.12 | 36.06 | 36.89 | 35.43 | 34.67 |
Vimta Labs Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 512.07
S2 502.88
S3 492.17
Pivot 522.78
R1 531.97
R2 542.68
R3 551.87
Moving Average
20 SMA 480.34
50 SMA 467.70
100 SMA 464.39
200 SMA 568.48
Vimta Labs Ltd Corporate Actions
Vimta Labs Ltd
₹2.0/Share
Announcement Date 30 May 2025
Record Date 30 May 2025
Div Yield 100%
Vimta Labs Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,495.95 | ₹1,22,158.73 |
| Max Healthcare Institute Ltd | ₹1,008.95 | ₹98,195.43 |
| Fortis Healthcare Ltd | ₹988.95 | ₹74,661.59 |
| Aster DM Healthcare Ltd | ₹814.20 | ₹42,185.41 |
| Narayana Hrudayalaya Ltd | ₹1,861.80 | ₹38,047.89 |
Vimta Labs Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Bandhan BSE Healthcare Index Fund | 0.05% |
Vimta Labs Ltd News
Vimta Labs to conduct AGM
On 25 June 2026
03 Jun 2026, 03:21 pm
Board of Vimta Labs recommends final dividend
Of Rs 2 per share
06 May 2026, 05:01 pm
Vimta Labs schedules board meeting
On 6 May 2026
30 Apr 2026, 10:45 am
Vimta Labs schedules board meeting
On 28 January 2026
22 Jan 2026, 10:30 am
Vimta Labs allots 94,369 equity shares under ESOP
17 Nov 2025, 06:40 pm
Vimta Labs Ltd Stock Analysis
- Annual revenue for Vimta Labs Ltd increased by 19.54% to ₹416.28 crore in FY 2026 from ₹348.22 crore in FY 2025.
- Annual Net Profit for Vimta Labs Ltd increased by 16.11% to ₹77.51 crore in FY 2026 from ₹66.75 crore in FY 2025.
- Promoter Shareholding in Vimta Labs Ltd decreased by 0.13% in the most recent quarter, from 35.90% in December 2025 to 35.85% in March 2026.
- Vimta Labs Ltd delivered a 1-year return of 6.96% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Vimta Labs Ltd share price moved up by 3.08% from its previous close of INR ₹521.25. The latest Vimta Labs Ltd share price is INR ₹537.30.
- Vimta Labs Ltd share price today has been at a low of 525 and a high of 538. Over the past 52 weeks, the Vimta Labs Ltd share price has seen a low of 376.05 and a high of 902.65.
About Vimta Labs Ltd
Vimta Labs Limited is a well-known contract research and testing organisation based in India. The company provides a variety of services, including analytical testing, clinical research, preclinical studies, safety testing, method development, process validation, and environmental assessments. These services support industries such as pharmaceuticals, food, agriculture, and environmental sectors.
Founded in 1984, Vimta Labs has been in business for decades and has a lot of experience in the field. Its headquarters is located in Secunderabad, Telangana. Over the years, the company has earned a reputation for delivering high-quality services. With that, it has grown its operations across multiple locations in India and even internationally.
The company is led by its promoters, including S.P. Vasireddi, who serves as the Executive Chairman, and Harita Vasireddi, the Managing Director. Here is a list of their other top managing promoters -
While Vimta Labs holds a solid position in India’s contract research and testing market. A notable factor is the promoter shareholding, which is at 36.89%. This reflects the confidence and dedication of the founding members toward the company’s growth and stability.
Vimta Labs' registered office and registrar are both located in Hyderabad, Telangana. The company is managed by a skilled team. Overall, Vimta Labs continues to be a trusted partner for various industries. This is thanks to their high-quality research and testing services to clients across many sectors.
In the early years, Vimta Labs concentrated mainly on analytical testing services. The company's attention to detail and adherence to international standards quickly earned it a positive reputation. This early success enabled the company to secure contracts with major pharmaceutical companies. From the start, Vimta Labs’ focus on quality and innovation made it a trusted partner for several well-known organisations.
As the demand for advanced research and testing services grew, Vimta Labs expanded its capabilities. In the 1990s, the company branched out into clinical research. They began offering new services like bioavailability and bioequivalence studies and pharmacovigilance. This expansion was fueled by the growing need for rigorous testing and validation in the pharmaceutical sector. This was very necessary, especially with the rise of generic drug manufacturing in India.
The early 2000s marked a period of significant growth and diversification for Vimta Labs. The company invested in advanced technology and established state-of-the-art facilities. These investments allowed Vimta Labs to offer an even broader range of services. It included preclinical (animal) studies, environmental assessments, and method development and validation. The ability to provide end-to-end solutions made Vimta Labs a preferred choice for clients looking for these services under one roof.
Vimta Labs has always maintained a strong commitment to quality and compliance, which has been a cornerstone of its success. Over the years, the company has earned numerous accreditations and certifications. These include ISO/IEC 17025, GLP (Good Laboratory Practice), and NABL (National Accreditation Board for Testing and Calibration Laboratories). These certifications show the company’s dedication to the highest quality standards in its services.
Vimta Labs’ success is also closely linked to its focus on organisational culture. The company places a high value on training and development. They believe in investing in their employees' continuous learning and improvement. This approach has allowed Vimta Labs to build a strong and capable workforce by attracting top talent.
Over the years, Vimta Labs has expanded its presence across India and beyond. The company has established multiple laboratories and offices. It has even formed various international collaborations and partnerships. These expansions have enabled the company to serve a wide range of clients. Having such a broad client base speaks to the company’s ability to deliver high-quality, reliable services.
Today, Vimta Labs is recognized as a leader in India’s contract research and testing industry. It continues to evolve and innovate, leveraging its decades of experience to meet the ever-changing needs of its clients. With a strong foundation built on quality and integrity, Vimta Labs is well-positioned to continue its legacy of excellence in the future.
The history of Vimta Labs showcases the vision and dedication of its founders and employees. From its modest start as a small laboratory, it has now grown into a leading provider of advanced research and testing services. The company’s journey has been marked by continuous innovation and reliable results. With its impressive track record, Vimta Labs is set to remain a trusted name in the industry for many years to come.
Founded in 1984, Vimta Labs has been in business for decades and has a lot of experience in the field. Its headquarters is located in Secunderabad, Telangana. Over the years, the company has earned a reputation for delivering high-quality services. With that, it has grown its operations across multiple locations in India and even internationally.
The company is led by its promoters, including S.P. Vasireddi, who serves as the Executive Chairman, and Harita Vasireddi, the Managing Director. Here is a list of their other top managing promoters -
- Harriman Vungal
- Satya Sreenivas Neerukonda
- Yadagiri R Pendri
While Vimta Labs holds a solid position in India’s contract research and testing market. A notable factor is the promoter shareholding, which is at 36.89%. This reflects the confidence and dedication of the founding members toward the company’s growth and stability.
Vimta Labs' registered office and registrar are both located in Hyderabad, Telangana. The company is managed by a skilled team. Overall, Vimta Labs continues to be a trusted partner for various industries. This is thanks to their high-quality research and testing services to clients across many sectors.
History of the Company
Vimta Labs Limited has a long history as a pioneering contract research and testing organisation in India. Established in 1984 by Dr. S.P. Vasireddi, who had a strong background in analytical chemistry. The company set out with a vision to create a world-class laboratory that could offer top-notch analytical services. The company’s target industries included pharmaceuticals, food, agriculture, and environmental sectors.In the early years, Vimta Labs concentrated mainly on analytical testing services. The company's attention to detail and adherence to international standards quickly earned it a positive reputation. This early success enabled the company to secure contracts with major pharmaceutical companies. From the start, Vimta Labs’ focus on quality and innovation made it a trusted partner for several well-known organisations.
As the demand for advanced research and testing services grew, Vimta Labs expanded its capabilities. In the 1990s, the company branched out into clinical research. They began offering new services like bioavailability and bioequivalence studies and pharmacovigilance. This expansion was fueled by the growing need for rigorous testing and validation in the pharmaceutical sector. This was very necessary, especially with the rise of generic drug manufacturing in India.
The early 2000s marked a period of significant growth and diversification for Vimta Labs. The company invested in advanced technology and established state-of-the-art facilities. These investments allowed Vimta Labs to offer an even broader range of services. It included preclinical (animal) studies, environmental assessments, and method development and validation. The ability to provide end-to-end solutions made Vimta Labs a preferred choice for clients looking for these services under one roof.
Vimta Labs has always maintained a strong commitment to quality and compliance, which has been a cornerstone of its success. Over the years, the company has earned numerous accreditations and certifications. These include ISO/IEC 17025, GLP (Good Laboratory Practice), and NABL (National Accreditation Board for Testing and Calibration Laboratories). These certifications show the company’s dedication to the highest quality standards in its services.
Vimta Labs’ success is also closely linked to its focus on organisational culture. The company places a high value on training and development. They believe in investing in their employees' continuous learning and improvement. This approach has allowed Vimta Labs to build a strong and capable workforce by attracting top talent.
Over the years, Vimta Labs has expanded its presence across India and beyond. The company has established multiple laboratories and offices. It has even formed various international collaborations and partnerships. These expansions have enabled the company to serve a wide range of clients. Having such a broad client base speaks to the company’s ability to deliver high-quality, reliable services.
Today, Vimta Labs is recognized as a leader in India’s contract research and testing industry. It continues to evolve and innovate, leveraging its decades of experience to meet the ever-changing needs of its clients. With a strong foundation built on quality and integrity, Vimta Labs is well-positioned to continue its legacy of excellence in the future.
The history of Vimta Labs showcases the vision and dedication of its founders and employees. From its modest start as a small laboratory, it has now grown into a leading provider of advanced research and testing services. The company’s journey has been marked by continuous innovation and reliable results. With its impressive track record, Vimta Labs is set to remain a trusted name in the industry for many years to come.
FAQ’s
What is the share price of Vimta Labs Ltd today?
Vimta Labs Ltd share price as on 12 Jun 2026 is ₹ 537.3
What is the Market Cap of Vimta Labs Ltd?
The market cap of Vimta Labs Ltd stock is ₹2,328.39 Cr.
What is the PE Ratio of Vimta Labs Ltd?
The Price to Earnings (P/E) Ratio of Vimta Labs Ltd is 21.95
What is the PB Ratio of Vimta Labs Ltd?
The Price to Book (P/B) Ratio of Vimta Labs Ltd is 3.72
What is the 52 week high of Vimta Labs Ltd Share Price?
The 52 week high of Vimta Labs Ltd share price stands at ₹902.65
What is the 52 week low of Vimta Labs Ltd Share Price?
The 52 week low of Vimta Labs Ltd share price stands at ₹376.05
How can I buy shares of Vimta Labs Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Vimta Labs Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
